3NX Stock Overview
An investment holding company, provides assisted reproductive services (ARS) in China and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Jinxin Fertility Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.34 |
| 52 Week High | HK$0.51 |
| 52 Week Low | HK$0.24 |
| Beta | 1.4 |
| 1 Month Change | -3.41% |
| 3 Month Change | 22.30% |
| 1 Year Change | -12.82% |
| 3 Year Change | -64.40% |
| 5 Year Change | -70.94% |
| Change since IPO | -63.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3NX | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -2.9% | -3.8% | -2.0% |
| 1Y | -12.8% | 15.6% | 6.9% |
Return vs Industry: 3NX underperformed the German Healthcare industry which returned 15.6% over the past year.
Return vs Market: 3NX underperformed the German Market which returned 6.9% over the past year.
Price Volatility
| 3NX volatility | |
|---|---|
| 3NX Average Weekly Movement | 12.8% |
| Healthcare Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 3NX's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 3NX's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 3,779 | Yang Dong | www.jxr-fertility.com |
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS.
Jinxin Fertility Group Limited Fundamentals Summary
| 3NX fundamental statistics | |
|---|---|
| Market cap | €950.63m |
| Earnings (TTM) | €40.83m |
| Revenue (TTM) | €380.77m |
23.3x
P/E Ratio2.5x
P/S RatioIs 3NX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3NX income statement (TTM) | |
|---|---|
| Revenue | CN¥2.90b |
| Cost of Revenue | CN¥1.70b |
| Gross Profit | CN¥1.19b |
| Other Expenses | CN¥883.30m |
| Earnings | CN¥310.84m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.11 |
| Gross Margin | 41.19% |
| Net Profit Margin | 10.72% |
| Debt/Equity Ratio | 20.9% |
How did 3NX perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield47%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 09:32 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jinxin Fertility Group Limited is covered by 30 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sharon Shi | BOCI Research Ltd. |
| Ethan Cui | BofA Global Research |
| Qianyi Li | China International Capital Corporation Limited |